Navigation Links
InkSure and AuthentiForm Announce Assignment of Patent Portfolio
Date:1/28/2008

Sublicense for Humanitarian Purposes Granted to Global Vaccines

FT. LAUDERDALE, Fla. and CHAPEL HILL, N.C., Jan. 28 /PRNewswire-FirstCall/ -- InkSure Technologies Inc. (OTC Bulletin Board: INKS), a leading provider of covert machine-readable security solutions ("CMRT") for the detection of counterfeiting, fraud and diversion, and AuthentiForm Technologies, L.L.C., a developer of innovative authentication and item-level identification technologies, today announced that they have entered into an assignment agreement by which InkSure has acquired AuthentiForm's entire intellectual property portfolio of enhanced product-authentication technology.

The AuthentiForm portfolio includes methods to establish authenticity and identify products at the item level by encoding high information-density, invisible, and essentially tamper-proof signatures within a product's formulation, on its surface, or through incorporation into its packaging. AuthentiForm technology enables dynamic codes without substantially changing the chemical composition of a product or its components, which makes the AuthentiForm technology particularly attractive for use with pharmaceutical products.

"We have been impressed with AuthentiForm's developments for some time and believe that its enhanced product identification techniques will be very compatible with a new InkSure product line in development," commented Yaron Meerfeld, Chief Operating Officer of InkSure Technologies Inc. "Brand owners want more than authentication products: they are looking for solutions," added Mr. Meerfeld. "We believe that this addition to our authentication and track-and-trace capabilities will offer new and exciting solutions to our portfolio."

"InkSure emerged as the assignee of choice because of its forward-thinking stance on the technology's value," stated AuthentiForm's Managing Owner Tom Mercolino.

As a further condition of the assignment agreement, InkSure has granted back to AuthentiForm the right to license its portfolio for humanitarian uses. AuthentiForm will sublicense some of the technology's humanitarian-use rights to Global Vaccines, Inc. (GVI), a non-profit vaccine company. "InkSure has shown its commitment to reducing the insidious effects of counterfeit products by agreeing that AuthentiForm may retain humanitarian-use rights," Mercolino said. "I am delighted that Global Vaccines will be able to use AuthentiForm to protect its vaccines for people in the developing world."

"The AuthentiForm technology will help Global fulfill its mission of delivering safe and effective vaccines to the developing world," said GVI's Director of Development Jake Wiltshire. "Because it will ensure that people in developing countries are not receiving counterfeit products, it's a wonderful addition to our existing vaccine portfolio."

About InkSure Technologies Inc.

InkSure Technologies Inc., with its corporate headquarters in Ft. Lauderdale, Florida and its research and development center in Science Park, Rehovot, Israel, specializes in comprehensive, covert security solutions designed to protect high profile brands and documents of value from counterfeiting, fraud and diversion. The Company's sales and marketing activities target a number of market opportunities, including financial, pharmaceutical, branded products, transportation, and government/institutional, on a global scale. The Company's R&D activities include the development of "chipless" RFID technology for affordable item-level secure logistics and track-and-trace applications.

The Company's common stock is listed on the OTC Bulletin Board under the symbol "INKS". Additional information on the Company is available on its website at http://www.inksure.com.

About AuthentiForm Technologies, L.L.C.

AuthentiForm Technologies, L.L.C. is a privately held company with an office in Chapel Hill, North Carolina. AuthentiForm's business focuses on developing methods to unequivocally establish product authenticity.

Statements contained in this Press Release, other than statements of historical facts, are forward-looking statements subject to a number of uncertainties that could cause actual events or results to differ materially from some statements made.

For further information, please contact:

InkSure:

James Assaf, General Manager, InkSure Inc. +1-954-772-8507 or via e-mail

at jassaf@inksure.com

AuthentiForm:

Thomas J. Mercolino, Managing Owner, AuthentiForm Technologies, L.L.C.,

908-963-9387 or via email at tmercolino@nc.rr.com.


'/>"/>
SOURCE InkSure Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. XLHealth Corporation Announces Executive Changes
2. Nanotech Briefs Announces Call for Nominations for the Fourth Annual Nano 50(TM) Awards
3. Massage Prep(TM) Announces Outreach Program
4. LCA-Vision Announces Upcoming Investment Community Events
5. Warner Chilcott Announces 2008 Financial Guidance
6. WellPoint Announces Appearance at Upcoming Conference
7. Elder Care Operator and Plaintiff Attorney Announce Unprecedented Settlement Agreement in Class Action Lawsuit
8. Mayo Clinic, Microsoft Announce Strategic Agreement to Develop Consumer Health Management Tools
9. inVentiv Health to Announce Fourth Quarter and Full Year 2007 Results and Conduct Conference Call on Thursday, February 28th
10. Global Health and Business Leaders Announce 36-Month Effort to Expand Malaria Control in Africa; 3.5 Million Lives Could be Saved in Five Years, Study Finds
11. OPKO Health Announces Changes to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... As pharmaceutical companies are held ... with process innovation in drug formulation and manufacturing. CoreRx offers its clients ... equipment in support of their development and manufacturing goals. , The company ...
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest ... chronic problems, I focus on preventative care with all my patients to alleviate possible future ... always feel free to contact my office and my trained staff will assist you in ...
(Date:4/25/2017)... ... April 25, 2017 , ... Emergency Physician and Distinguished Professor of Emergency ... Series, Outliers in Writing, set to publish in summer 2017. , Dr. Bobrow, ... University of Arizona College of Medicine. He also serves as Medical Director for the ...
(Date:4/25/2017)... ... ... Vetoquinol USA® , a world-class developer of veterinarian-approved ... EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin UCII ... The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and joints. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: ... that address significant unmet medical needs, today announced ... Company,s consumer product development program, based on its ... for Investigative Dermatology (SID) 76 th Annual ... promote the sciences relevant to skin health and ...
(Date:4/20/2017)... 2017  AbbVie (NYSE: ABBV), a global biopharmaceutical ... chronic hepatitis C virus (HCV) infected patients with ... compensated cirrhosis (Child-Pugh A) achieved sustained virologic response ... its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These ... 12 weeks of G/P treatment without ribavirin. Patients ...
(Date:4/20/2017)... Research and Markets has announced the addition of ... By Service (Manufacturing, Research), By Country, (Brazil, Mexico, Colombia, Argentina, ... to their offering. ... The Latin American pharmaceutical contract manufacturing services market is anticipated ... drug registration cost in Latin American countries and continuous economic ...
Breaking Medicine Technology: